In the pipeline: non-stimulant ADHD MEDS: stimulant side effects drive development of alternative medications.(RX RESOURCES)(attention-deficit ... An article from: Behavioral Healthcare

This digital document is an article from Behavioral Healthcare, published by Vendome Group LLC on January 1, 2010. The length of the article is 1228 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: In the pipeline: non-stimulant ADHD MEDS: stimulant side effects drive development of alternative medications.(RX RESOURCES)(attention-deficit hyperactivity disorder)(Report)
Author: William M. Glazer
Publication:Behavioral Healthcare (Magazine/Journal)
Date: January 1, 2010
Publisher: Vendome Group LLC
Volume: 30 Issue: 1 Page: 30(2)

Article Type: Report

Distributed by Gale, a part of Cengage Learning